Contents of this document
- Upward Revision to the Full-Year Earnings Forecast
- ¥6 increase in the annual dividend forecast
- Acquisition of 1 million treasury shares
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Net Sales | 36,575 Millions of yen (YoY +11.1%) |
| Operating profit | 1,681 Millions of yen (YoY +41.6%) |
| Ordinary income | 1,965 Millions of yen (YoY +38.0%) |
| Net income | 1,457 Millions of yen (YoY +20.9%) |
| Selling, general and administrative expenses | 3,514 Millions of yen |
| Full-year earnings forecast | Net Sales 74,000 Millions of yen / Operating profit 3,400 Millions of yen / Ordinary income 3,900 Millions of yen / Profit attributable to owners of the parent 2,800 Millions of yen |
| Progress against full-year forecast | Net Sales 49.4 % / Operating profit 49.4 % / Ordinary income 50.3 % / Profit attributable to owners of the parent 52 % |
| Segment results | Chemicals Business Net Sales 23,667 Millions of yen (YoY +7.3%) / Segment profit 2,095 Millions of yen (YoY +11.0%) / Functional Materials business Net Sales 9,299 Millions of yen (YoY +33.1%) / Segment profit 641 Millions of yen (YoY +56.3%) / Other businesses Net Sales 3,609 Millions of yen (YoY -7.2%) / Segment profit 207 Millions of yen (YoY +67.9%) |
| Assumptions Underlying the Business Outlook | Price revisions for major chemicals and the acceptance inspection of packaging-related equipment, among other items, are scheduled. |
| Medium-term management plan targets | Initiatives are being advanced as the final year of the medium-term management plan, “Go forward STAGE3.” |
| Annual Dividend | ¥50 per share |
| Payout ratio | 40 |
| Acquisition of treasury shares | Number of Shares 1,000,000 / Period Not disclosed / Amount Not disclosed |
| New initiatives | Upward Revision to the Full-Year Earnings Forecast, ¥6 increase in the annual dividend forecast, Acquisition of 1 million treasury shares |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited stronger demand against the backdrop of the situation in the Middle East, price revisions for various products, solid sales activity and controlled selling, general and administrative expenses as reasons for the increases in revenue and profit. Price revisions for major chemicals and the acceptance inspection of packaging-related equipment are scheduled for the second half.